Opus Genetics Inc (NASDAQ: IRD) – Suitable For Long Term Buy?
Currently, there are 45.48M common shares owned by the public and among those 39.42M shares have been available to trade. The company’s stock has a 5-day price change of 6.86% and 12.16% over the past three months. IRD shares are trading -8.40% year to date (YTD), with the 12-month market performance down to -36.07% lower. […]